Navigation Links
Xeloda XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
Date:9/7/2007

SAN FRANCISCO, Sept. 7 /PRNewswire/ -- Roche announced today that three clinical data abstracts about its oral chemotherapy treatment Xeloda have been accepted for presentation at the 2007 Breast Cancer Symposium in San Francisco, Sept. 7 and 8.

Two of the abstracts include data from the XeNA (Xeloda in NeoAdjuvant) trial, a study of Xeloda and docetaxel with or without Herceptin in patients with invasive breast cancer. The third presentation highlights findings that validate efficacy and cost benefits of Xeloda in breast cancer patients.

-- Poster No. A54, [General Poster Session A, Sept. 7, 12:00 - 12:45

p.m.], "Frequency of circulating tumor cells (CTCs) in an open-label

study of neoadjuvant capecitabine, docetaxel and trastuzumab (CDT)

combination therapy in patients with HER2+ breast cancer (BC)."

(Presenter: Stefan Gluck)

-- Poster No. 100, [General Poster Session C, Sept. 8, 7:00 - 8:00 a.m.],

"Distribution of p53 mutations by AmpliChip assay in patients receiving

neoadjuvant capecitabine (C) plus docetaxel (D) with or without

trastuzumab (T) for newly diagnosed breast cancer (BC)." (Presenter:

Nancy Patten)

-- Poster No. A41, [General Poster Session D, Sept. 8, 11:45 a.m. - 12:45

p.m.], "Capecitabine is associated with fewer adverse events than other

standard therapies in patients with breast cancer: a claims database

analysis." (Presenter: Hope Rugo, M.D.)

These studies affirm Roche's commitment to exploring the expanded use of Xeloda in combination with new therapies. Additionally, the data explore the potential of oral Xeloda to offer effective treatment with a lower incidence of adverse events compared with traditional intravenous chemotherapy.

About Xeloda

Xeloda is the only FDA-approved oral chemotherapy for both metastatic breast cancer and adjuvant and metastatic colorectal cancer. Inactive in pill for
'/>"/>

SOURCE Roche
Copyright©2007 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2 3

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...,, BASKINGRIDGE,N.J.,Nov.25/PRNewswire/--Regado...mentofantithromboticaptamerswithactivecontrolagent...bepresentingatthePiperJaffray21stAnnualHealthCareC...azzo,spresentationwillbegivenat1:10pm(EST)onTuesda...ipelinewithemphasisontheleaddevelopmentprogram,the...
(Date:11/25/2009)...,, UNIONCITY,Calif.,Nov.25/PRNewswire-FirstCall...anymanufacturingpoint-of-carebloodanalysissystems,...ecutiveofficer,willpresentatthe21stAnnualPiperJaff...t2:00p.m.ET.TheconferencewillbeheldattheNewYorkPal...baxisdevelops,manufacturesandmarketsportableblooda...
(Date:11/25/2009)...,, CHAPELHILL,N.C.,Nov.25/PRNewswire/--CempraPh...andes,presidentandchiefexecutiveofficer,willpresen...8:50a.m.EST,December1,2009,atTheNewYorkPalaceHotel...hecompany,stwoleadingantibioticclinicalprogramsfor.... ,, AboutCempraPharmaceuticals ,, Founded...
Breaking Medicine Technology:Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Diabetes Conversation Map 28TM 29 Education Tools Celebrate One Year Anniversary 5639 1Diabetes Conversation Map 28TM 29 Education Tools Celebrate One Year Anniversary 5639 2Diabetes Conversation Map 28TM 29 Education Tools Celebrate One Year Anniversary 5639 3Diabetes Conversation Map 28TM 29 Education Tools Celebrate One Year Anniversary 5639 4Diabetes Conversation Map 28TM 29 Education Tools Celebrate One Year Anniversary 5639 5Laureate Pharma Announces Signing New Biopharmaceutical Development 26amp 3B Manufacturing Agreement 5637 1Laureate Pharma Announces Signing New Biopharmaceutical Development 26amp 3B Manufacturing Agreement 5637 2MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 10458 1MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 10458 2MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 10458 3
...Bifantis shows ability to limit inflammation in mo...ing to data presented at,Digestive Disease Week -,...echnology,company Alimentary Health today announce...ti-inflammatory activity of a natural,probiotic ba...obacterium infantis 35624), in models of arthritis...
...ISTOL, Tenn.--(BUSINESS WIRE)--May 19, 2007 - King...at data from its,Phase III clinical trial evaluati...LTACE 20mg and hydrochlorothiazide (HCT) 25mg were... Hypertension,Inc. (ASH) Twenty-Second Annual Sci...go, Illinois. The clinical trial data showed,that ...
Other Medicine Technology:New Data On the Probiotic Strain Bifantis Shows Anti-Inflammatory,Properties and Increased Health Benefits 2New Data On the Probiotic Strain Bifantis Shows Anti-Inflammatory,Properties and Increased Health Benefits 3King Pharmaceuticals Reports Efficacy of Altace 20mg And Efficacy,of a Combination of Altace 20mg And Hydrochlorothiazide 25mg For,24-hour Blood Pressure Control 2King Pharmaceuticals Reports Efficacy of Altace 20mg And Efficacy,of a Combination of Altace 20mg And Hydrochlorothiazide 25mg For,24-hour Blood Pressure Control 3King Pharmaceuticals Reports Efficacy of Altace 20mg And Efficacy,of a Combination of Altace 20mg And Hydrochlorothiazide 25mg For,24-hour Blood Pressure Control 4King Pharmaceuticals Reports Efficacy of Altace 20mg And Efficacy,of a Combination of Altace 20mg And Hydrochlorothiazide 25mg For,24-hour Blood Pressure Control 5
(Date:11/26/2009)...e/--Withcoldandfluseasonuponus,it,smoreimportantth...ectionsandavoidillness. ,, "Weneedtobeproactive...ngillnessifwe,resick,"saidEileenFinerty,RN,MS,CIC(...fectioncontrolandoccupationalhealthatHospitalforSp...cialSurgeryhasoneofthelowestinfectionratesofanyhos...
(Date:11/26/2009)...etrathiomolybdate (TM) has been shown in studies t... a disease caused by an overload of copper, and ce... little, however, is known about how the drug work...orthwestern University researchers now has provide...ure of TM bound to copper-loaded metallochaperones...
(Date:11/26/2009)...e letters from the North Pole, Textsanta.net lets ...m Santa , North Pole, AK ...ficiencies at the North Pole Santa Claus has added... the globe informed of his Christmas progress at t... department have identified a large and growing pe...
(Date:11/26/2009)... Communications announces a highly effective and u... struggling to make an economic recovery. , ...u fears is the type of challenge that could send a...ng to Dr. David Benton, business growth expert and...em – The Rfactor Intensive . “Fear ...
(Date:11/25/2009)...Newswire/--TheBartleHallConventionCenterwilltempor...10,whenKansasCityhoststhelatestinaseriesofmassivef...ceventhasthepotentialtobethebiggestoneyet,becausei...eekdaysinsteadofoveraweekend,"SheriWood,executived...oftheNationalAssociationofFreeClinics(NAFC). ,,...
Breaking Medicine News(10 mins):Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Kansas City Prepares for Largest Free Health Clinic 2
...Med, Inc. (OTC,Bulletin Board: SYMD), a biomateria...alization of anti-adhesion and drug delivery produ... P. Hickey will present at the 2007,Lazard Capital...rkets will host a web cast of the presentation liv...
...gredients-Makers, LONDON, November 20 Internatio...f naturally extracted food,ingredients such as Reb...,Investment Banking,s former Deputy Chairman - as ...f Singer & Friedlander,as well as through his curr...
...Newswire-FirstCall/ -- China Holdings,Inc., a glob...sidiaries,engage in multiple China-focused busines...sources, utilities, finance, real estate, and,phar...ant with a power capacity of 50 MW through its con...
...FirstCall/ - Novadaq(R) Technologies Inc.,(TSX: ND...ms and image,guided therapies for the operating ro...nt & CEO of Novadaq, will present the corporate st...nce runs from Tuesday, November 27 through Thursda...
...0 The Oral Cancer,Foundation announced today that...cancer detection would be the foundation,s first g...n ongoing commitment to each,researcher, were awar...f the University of Texas MD Anderson Cancer,Cente...
... by Six Million; AHF Questions Numbers, Seeks ...S, Nov. 20 As the World Health,Organization (WHO)...l AIDS,cases from an estimated high of 39 million ...r of people thought to be,living with HIV/AIDS wor...
Other Medicine News:Health News:Ex-HSBC Man Joins PureCircle 2Health News:China Holdings, Inc. Announces Its 3rd Biomass Renewable Energy Project (Power Capacity: 50 MW); Total Potential: 150 MW in Biomass Energy Pipeline 2Health News:China Holdings, Inc. Announces Its 3rd Biomass Renewable Energy Project (Power Capacity: 50 MW); Total Potential: 150 MW in Biomass Energy Pipeline 3Health News:China Holdings, Inc. Announces Its 3rd Biomass Renewable Energy Project (Power Capacity: 50 MW); Total Potential: 150 MW in Biomass Energy Pipeline 4Health News:China Holdings, Inc. Announces Its 3rd Biomass Renewable Energy Project (Power Capacity: 50 MW); Total Potential: 150 MW in Biomass Energy Pipeline 5Health News:China Holdings, Inc. Announces Its 3rd Biomass Renewable Energy Project (Power Capacity: 50 MW); Total Potential: 150 MW in Biomass Energy Pipeline 6Health News:China Holdings, Inc. Announces Its 3rd Biomass Renewable Energy Project (Power Capacity: 50 MW); Total Potential: 150 MW in Biomass Energy Pipeline 7Health News:Novadaq to present at Piper Jaffray Healthcare Conference 2Health News:The Oral Cancer Foundation Issues First Research Grants 2Health News:The Oral Cancer Foundation Issues First Research Grants 3Health News:WHO's New Global AIDS Numbers: 'Let's Stop Guessing,' Says AHF 2
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
Medicine Products: